ALX Oncology Holdings Inc. (NASDAQ ... our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame.

ALX Oncology, a Bay Area biotech firm currently running clinical trials for its anticancer therapy, announced Wednesday that it’s laying off about 30% of its staff. ALX shared the news in a ...

Alexander’s, Inc. (NYSE: ALX) is a real estate investment trust (“REIT”), incorporated in Delaware, engaged in leasing, managing, developing and redeveloping its properties. All references ...

Fresh from a $105 million third-round financing earlier this month, ALX Oncology has won two FDA fast-track designations for its lead immuno-oncology drug. The Irish-American biotech picked up the ...

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for ...

ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload ...

Through the ALX Pathway programme, eight Rwandan students have secured full scholarships to the African Leadership College (ALCHE) in Mauritius. Pathway, a groundbreaking initiative by ALX Rwanda, ...

On a warm digital stage, over 1,000 current and aspiring young Africans in tech gathered for the HER Power, Africa's Transformation ...